Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L13a pseudogene 7 (RPL13AP7)
- Target
- RPL13AP7
- Molecular classification
- Pseudogene, Processed pseudogene, Non-coding RNA gene (as pseudogenes are a subclass of long non-coding RNAs)
01
Overview
Ribosomal protein L13a pseudogene 7 (RPL13AP7) is a processed pseudogene found in the human genome that originated from the functional ribosomal protein L13a gene. Pseudogenes such as RPL13AP7 do not encode functional proteins due to sequence mutations and are not considered therapeutic targets. Instead, they may participate in various regulatory activities at the RNA level, though no specific roles have been identified for RPL13AP7 itself in health or disease. No drugs, disease associations, or biomarkers are described for RPL13AP7, and it is not implicated in notable safety or therapeutic concerns. The designation "pseudogene" serves to distinguish it from functional protein-coding genes and emphasizes that it should not be targeted in conventional pharmacological or therapeutic contexts.
- Other names
- RPL13AP7Ribosomal protein L13a pseudogene 7Sometimes referenced by Ensembl or gene IDs (e.g., ENSG00000213885)
02
Mechanism of action
Not applicable (no drugs or therapeutic actions described for this pseudogene)
03
Biological functions
No protein-coding functionMay participate in gene regulation via RNA-mediated mechanisms, such as acting as competing endogenous RNAs (ceRNAs), antisense transcripts, and miRNA spongesIn general, pseudogenes can modulate transcription and post-transcriptional regulatory networks, but specific functions for RPL13AP7 have not been established
04
Disease associations
No direct evidence linking RPL13AP7 to specific diseases or pathologiesSome pseudogenes have been associated with cancer or used as biomarkers, but no such role has been established for RPL13AP7 as per available databases and literature
05
Safety considerations
None known (no therapeutic targeting or safety issues described for this pseudogene)
06
Interacting drugs
None known
07
Biomarkers
None known (not used for patient selection or efficacy monitoring in current literature)
Beyond the preview
Go deeper on Ribosomal protein L13a pseudogene 7 (RPL13AP7).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L13a pseudogene 7 (RPL13AP7).